INCYINCYTE CORP
- Market cap
- $23.45B
- as of 2026-10-23
- Latest close
- $115.71
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-03
Dashed line = amended filing (Form 4/A)
Showing the latest 500 of 568 transactions.
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | M | 839 | $71.93 | $60,349 | 184,039 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | M | 423 | $61.76 | $26,124 | 184,462 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | M | 455 | $61.18 | $27,837 | 184,917 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | M | 925 | $64.25 | $59,431 | 185,842 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | S | 2,642 | $112.71 | Sale −$297,780 | 183,200 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | M · derivative | 839 | $71.93 | $60,349 | 17,627 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | M · derivative | 423 | $61.76 | $26,124 | 3,802 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | M · derivative | 455 | $61.18 | $27,837 | 4,096 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Oct 15 | Oct 19 | M · derivative | 925 | $64.25 | $59,431 | 19,431 | Yes | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Oct 1 | Oct 5 | F | 463 | $117.14 | $54,236 | 37,578 | No | Form 4 |
| Baker Bros. Advisors LP | Sep 30 | Oct 2 | A | 322 | $0.00 | $0 | 2,835,403 | No | Form 4 |
| Baker Bros. Advisors LP | Sep 30 | Oct 2 | A | 322 | $0.00 | $0 | 28,206,082 | No | Form 4 |
| Harrigan Edmund | Sep 30 | Oct 2 | A | 206 | $121.35 | $24,998 | 23,225 | No | Form 4 |
| Clancy Paul J | Sep 30 | Oct 2 | A | 203 | $121.35 | $24,634 | 25,838 | No | Form 4 |
| Gardner David HEVP, Chief Strategy Officer | Sep 22 | Sep 24 | F | 920 | $126.93 | $116,776 | 15,904 | No | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | M | 2,957 | $61.76 | $182,624 | 186,157 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | M | 4,551 | $61.18 | $278,430 | 190,708 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | M | 6,477 | $64.25 | $416,147 | 197,185 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | M | 9,233 | $71.93 | $664,130 | 206,418 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | S | 9,233 | $120.50 | Sale −$1,112,577 | 197,185 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | S | 13,985 | $120.49 | Sale −$1,685,053 | 183,200 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | M · derivative | 2,957 | $61.76 | $182,624 | 4,225 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | M · derivative | 4,551 | $61.18 | $278,430 | 4,551 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | M · derivative | 6,477 | $64.25 | $416,147 | 20,356 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Sep 15 | Sep 17 | M · derivative | 9,233 | $71.93 | $664,130 | 18,466 | Yes | Form 4 |
| Basi Ramitpal KEVP, Human Resources | Aug 25 | Aug 27 | F | 504 | $129.72 | $65,379 | 10,993 | No | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Aug 19 | Aug 20 | S | 10,801 | $125.56 | Sale −$1,356,174 | 183,200 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Aug 12 | Aug 14 | S | 10,803 | $120.04 | Sale −$1,296,792 | 194,001 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Aug 5 | Aug 7 | S | 10,640 | $122.69 | Sale −$1,305,422 | 204,804 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Aug 5 | Aug 7 | M | 2,207 | $106.47 | $234,979 | 63,648 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Aug 5 | Aug 7 | S | 2,207 | $123.99 | Sale −$273,646 | 61,441 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Aug 5 | Aug 7 | M · derivative | 2,207 | $106.47 | $234,979 | not reported | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Aug 3 | Aug 4 | M | 6,055 | $105.43 | $638,379 | 67,496 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Aug 3 | Aug 4 | S | 6,055 | $120.43 | Sale −$729,204 | 61,441 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Aug 3 | Aug 4 | M · derivative | 6,055 | $105.43 | $638,379 | not reported | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Jul 31 | Aug 4 | S | 15,888 | $119.70 | Sale −$1,901,794 | 215,444 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 2,918 | $61.18 | $178,523 | 66,546 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 2,284 | $64.25 | $146,747 | 68,830 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 2,709 | $61.76 | $167,308 | 71,539 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 3,148 | $68.62 | $216,016 | 74,687 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 2,072 | $71.93 | $149,039 | 76,759 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 9,459 | $72.27 | $683,602 | 86,218 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 2,623 | $74.78 | $196,148 | 88,841 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 2,864 | $77.67 | $222,447 | 91,705 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 1,643 | $80.50 | $132,262 | 93,348 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 3,023 | $83.20 | $251,514 | 96,371 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 2,623 | $83.58 | $219,230 | 98,994 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 1,642 | $85.01 | $139,586 | 100,636 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 2,293 | $90.56 | $207,654 | 102,929 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 85 | $106.47 | $9,050 | 103,014 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M | 326 | $105.43 | $34,370 | 103,340 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 14,661 | $119.46 | Sale −$1,751,403 | 88,679 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 5,332 | $119.42 | Sale −$636,747 | 83,347 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 2,187 | $119.47 | Sale −$261,281 | 81,160 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 6,171 | $119.43 | Sale −$737,003 | 74,989 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 4,695 | $119.39 | Sale −$560,536 | 70,294 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 2,864 | $119.40 | Sale −$341,962 | 67,430 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 1,643 | $119.51 | Sale −$196,355 | 65,787 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 1,642 | $119.38 | Sale −$196,022 | 64,145 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 85 | $122.19 | Sale −$10,386 | 64,060 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 326 | $121.69 | Sale −$39,671 | 63,734 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | S | 2,293 | $119.41 | Sale −$273,807 | 61,441 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 2,918 | $61.18 | $178,523 | 1,328 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 2,284 | $64.25 | $146,747 | 2,938 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 2,709 | $61.76 | $167,308 | 1,233 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 3,148 | $68.62 | $216,016 | not reported | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 2,072 | $71.93 | $149,039 | 2,665 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 9,459 | $72.27 | $683,602 | not reported | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 2,623 | $74.78 | $196,148 | not reported | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 2,864 | $77.67 | $222,447 | 191 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 1,643 | $80.50 | $132,262 | not reported | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 3,023 | $83.20 | $251,514 | 202 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 2,623 | $83.58 | $219,230 | not reported | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 1,642 | $85.01 | $139,586 | not reported | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 2,293 | $90.56 | $207,654 | not reported | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 85 | $106.47 | $9,050 | 2,207 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 31 | Aug 4 | M · derivative | 326 | $105.43 | $34,370 | 6,055 | Yes | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Jul 23 | Jul 27 | A · derivative | 6,426 | $116.69 | $749,850 | 6,426 | No | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Jul 23 | Jul 27 | A · derivative | 8,999 | $0.00 | $0 | 8,999 | No | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Jul 23 | Jul 27 | A · derivative | 15,423 | $116.69 | $1,799,710 | 15,423 | No | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Jul 23 | Jul 27 | A · derivative | 13,498 | $0.00 | $0 | 13,498 | No | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Jul 16 | Jul 20 | A | 13,403 | $0.00 | $0 | 231,332 | No | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Jul 16 | Jul 20 | A · derivative | 33,508 | $0.00 | $0 | 33,508 | No | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Jul 16 | Jul 20 | A · derivative | 57,861 | $116.65 | $6,749,486 | 57,861 | No | Form 4 |
| Meury WilliamChief Executive Officer | Jul 16 | Jul 20 | A | 26,807 | $0.00 | $0 | 183,129 | No | Form 4 |
| Meury WilliamChief Executive Officer | Jul 16 | Jul 20 | A · derivative | 80,421 | $0.00 | $0 | 80,421 | No | Form 4 |
| Meury WilliamChief Executive Officer | Jul 16 | Jul 20 | A · derivative | 77,148 | $116.65 | $8,999,314 | 77,148 | No | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Jul 16 | Jul 20 | S | 1,877 | $114.73 | Sale −$215,348 | 21,118 | Yes | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Jul 16 | Jul 20 | A | 9,798 | $0.00 | $0 | 30,916 | Yes | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Jul 16 | Jul 20 | A · derivative | 24,496 | $0.00 | $0 | 24,496 | Yes | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Jul 16 | Jul 20 | A · derivative | 42,298 | $116.65 | $4,934,062 | 42,298 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 16 | Jul 20 | A | 2,834 | $0.00 | $0 | 21,699 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 16 | Jul 20 | A · derivative | 4,079 | $116.65 | $475,815 | 4,079 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of U.S. Commercial | Jul 16 | Jul 20 | S | 1,093 | $115.01 | Sale −$125,706 | 63,940 | Yes | Form 4 |
| Issa Mohamed KhairieEVP, Head of U.S. Commercial | Jul 16 | Jul 20 | A | 7,857 | $0.00 | $0 | 71,797 | Yes | Form 4 |
| Issa Mohamed KhairieEVP, Head of U.S. Commercial | Jul 16 | Jul 20 | A · derivative | 19,643 | $0.00 | $0 | 19,643 | Yes | Form 4 |
| Issa Mohamed KhairieEVP, Head of U.S. Commercial | Jul 16 | Jul 20 | A · derivative | 33,918 | $116.65 | $3,956,535 | 33,918 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 16 | Jul 20 | A | 5,916 | $0.00 | $0 | 63,628 | No | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 16 | Jul 20 | A · derivative | 14,790 | $0.00 | $0 | 14,790 | No | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 16 | Jul 20 | A · derivative | 25,538 | $116.65 | $2,979,008 | 25,538 | No | Form 4 |
| Basi Ramitpal KEVP, Human Resources | Jul 16 | Jul 20 | A | 4,991 | $0.00 | $0 | 11,497 | No | Form 4 |
| Basi Ramitpal KEVP, Human Resources | Jul 16 | Jul 20 | A · derivative | 12,479 | $0.00 | $0 | 12,479 | No | Form 4 |
| Basi Ramitpal KEVP, Human Resources | Jul 16 | Jul 20 | A · derivative | 21,548 | $116.65 | $2,513,574 | 21,548 | No | Form 4 |
| Gardner David HEVP, Chief Strategy Officer | Jul 16 | Jul 20 | A | 7,395 | $0.00 | $0 | 16,824 | No | Form 4 |
| Gardner David HEVP, Chief Strategy Officer | Jul 16 | Jul 20 | A · derivative | 18,487 | $0.00 | $0 | 18,487 | No | Form 4 |
| Gardner David HEVP, Chief Strategy Officer | Jul 16 | Jul 20 | A · derivative | 31,923 | $116.65 | $3,723,818 | 31,923 | No | Form 4 |
| Hoffman Richard A.EVP & General Counsel | Jul 16 | Jul 20 | A | 7,395 | $0.00 | $0 | 16,861 | No | Form 4 |
| Hoffman Richard A.EVP & General Counsel | Jul 16 | Jul 20 | A · derivative | 18,487 | $0.00 | $0 | 18,487 | No | Form 4 |
| Hoffman Richard A.EVP & General Counsel | Jul 16 | Jul 20 | A · derivative | 31,923 | $116.65 | $3,723,818 | 31,923 | No | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Jul 15 | Jul 16 | F | 4,950 | $115.09 | $569,696 | 217,929 | No | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Jul 15 | Jul 16 | S | 28,237 | $113.05 | Sale −$3,192,193 | 26,083 | Yes | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Jul 15 | Jul 16 | F | 3,088 | $115.09 | $355,398 | 22,995 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 15 | Jul 16 | F | 1,098 | $115.09 | $126,369 | 18,865 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of U.S. Commercial | Jul 15 | Jul 16 | F | 1,099 | $115.09 | $126,484 | 65,033 | No | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 15 | Jul 16 | F | 1,512 | $115.09 | $174,016 | 57,712 | No | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Jul 14 | Jul 16 | F | 17,969 | $114.88 | $2,064,279 | 222,879 | No | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Jul 14 | Jul 16 | F | 21,830 | $114.88 | $2,507,830 | 54,320 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 14 | Jul 16 | F | 692 | $114.88 | $79,497 | 19,963 | No | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 14 | Jul 16 | F | 437 | $114.88 | $50,203 | 59,224 | No | Form 4 |
| Meury WilliamChief Executive Officer | Jul 2 | Jul 7 | F | 4,779 | $116.86 | $558,474 | 156,322 | No | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Jul 2 | Jul 7 | F | 2,177 | $116.86 | $254,404 | 76,150 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 2 | Jul 7 | F | 477 | $116.86 | $55,742 | 20,655 | No | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jul 2 | Jul 7 | F | 350 | $116.86 | $40,901 | 59,661 | No | Form 4 |
| Harrigan Edmund | Jun 30 | Jul 2 | A | 255 | $113.36 | $28,907 | 23,019 | No | Form 4 |
| Baker Felix | Jun 30 | Jul 2 | A | 400 | $0.00 | $0 | 2,835,081 | No | Form 4 |
| Baker Felix | Jun 30 | Jul 2 | A | 400 | $0.00 | $0 | 28,205,760 | No | Form 4 |
| Clancy Paul J | Jun 30 | Jul 2 | A | 252 | $113.36 | $28,567 | 25,635 | No | Form 4 |
| Harrigan Edmund | Jun 8 | Jun 10 | A | 1,642 | $0.00 | $0 | 22,764 | No | Form 4 |
| Harrigan Edmund | Jun 8 | Jun 10 | A · derivative | 6,111 | $100.64 | $615,011 | 6,111 | No | Form 4 |
| Baker Bros. Advisors LP | Jun 8 | Jun 10 | A | 1,642 | $0.00 | $0 | 2,834,681 | No | Form 4 |
| Baker Bros. Advisors LP | Jun 8 | Jun 10 | A | 1,642 | $0.00 | $0 | 28,205,360 | No | Form 4 |
| Baker Bros. Advisors LP | Jun 8 | Jun 10 | A · derivative | 6,111 | $100.64 | $615,011 | 6,111 | No | Form 4 |
| Baker Bros. Advisors LP | Jun 8 | Jun 10 | A · derivative | 6,111 | $100.64 | $615,011 | 6,111 | No | Form 4 |
| Brawley Otis W | Jun 8 | Jun 10 | A | 1,642 | $0.00 | $0 | 12,894 | No | Form 4 |
| Brawley Otis W | Jun 8 | Jun 10 | A · derivative | 6,111 | $100.64 | $615,011 | 6,111 | No | Form 4 |
| Bienaime Jean Jacques | Jun 8 | Jun 10 | A | 1,642 | $0.00 | $0 | 24,424 | No | Form 4 |
| Bienaime Jean Jacques | Jun 8 | Jun 10 | A · derivative | 6,111 | $100.64 | $615,011 | 6,111 | No | Form 4 |
| Fouse Jacqualyn A | Jun 8 | Jun 10 | A | 1,642 | $0.00 | $0 | 20,968 | No | Form 4 |
| Fouse Jacqualyn A | Jun 8 | Jun 10 | A · derivative | 6,111 | $100.64 | $615,011 | 6,111 | No | Form 4 |
| Clancy Paul J | Jun 8 | Jun 10 | A | 1,642 | $0.00 | $0 | 25,383 | No | Form 4 |
| Clancy Paul J | Jun 8 | Jun 10 | A · derivative | 6,111 | $100.64 | $615,011 | 6,111 | No | Form 4 |
| High Katherine A | Jun 8 | Jun 10 | A | 1,642 | $0.00 | $0 | 14,983 | No | Form 4 |
| High Katherine A | Jun 8 | Jun 10 | A · derivative | 6,111 | $100.64 | $615,011 | 6,111 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jun 4 | Jun 8 | M | 2,639 | $83.83 | $221,227 | 23,771 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jun 4 | Jun 8 | S | 2,639 | $100.00 | Sale −$263,900 | 21,132 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jun 4 | Jun 8 | M · derivative | 2,639 | $83.83 | $221,227 | not reported | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Jun 1 | Jun 3 | F | 25,469 | $95.59 | $2,434,582 | 240,848 | No | Form 4 |
| Bienaime Jean Jacques | May 26 | May 28 | M | 15,000 | $84.53 | $1,267,950 | 35,841 | Yes | Form 4 |
| Bienaime Jean Jacques | May 26 | May 28 | F | 13,059 | $97.10 | $1,268,029 | 22,782 | Yes | Form 4 |
| Bienaime Jean Jacques | May 26 | May 28 | M · derivative | 15,000 | $84.53 | $1,267,950 | not reported | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | May 26 | May 28 | S | 2,051 | $97.35 | Sale −$199,665 | 21,132 | Yes | Form 4 |
| Clancy Paul J | May 19 | May 21 | M | 15,000 | $84.53 | $1,267,950 | 38,741 | Yes | Form 4 |
| Clancy Paul J | May 19 | May 21 | S | 15,000 | $94.93 | Sale −$1,423,950 | 23,741 | Yes | Form 4 |
| Clancy Paul J | May 19 | May 21 | M · derivative | 15,000 | $84.53 | $1,267,950 | not reported | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | May 6 | May 204/A | A | 31,517 | $0.00 | $0 | 266,317 | No | Form 4/A |
| Stein Steven HCMO & Head of Late-Stage Dev. | May 6 | May 204/A | A | 44,124 | $0.00 | $0 | 78,327 | No | Form 4/A |
| Baker Bros. Advisors LP | May 8 | May 11 | M | 15,000 | $84.53 | $1,267,950 | 2,833,039 | No | Form 4 |
| Baker Bros. Advisors LP | May 8 | May 11 | M | 15,000 | $84.53 | $1,267,950 | 28,203,718 | No | Form 4 |
| Baker Bros. Advisors LP | May 8 | May 11 | M · derivative | 15,000 | $84.53 | $1,267,950 | not reported | No | Form 4 |
| Baker Bros. Advisors LP | May 8 | May 11 | M · derivative | 15,000 | $84.53 | $1,267,950 | not reported | No | Form 4 |
| Upadhyay SuketuEVP & Chief Financial Officer | May 4 | May 6 | A | 26,343 | $0.00 | $0 | 26,343 | No | Form 4 |
| Upadhyay SuketuEVP & Chief Financial Officer | May 4 | May 6 | A · derivative | 38,429 | $97.14 | $3,732,993 | 38,429 | No | Form 4 |
| Upadhyay SuketuEVP & Chief Financial Officer | May 4 | May 6 | A · derivative | 13,171 | $0.00 | $0 | 26,342 | No | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Apr 17 | Apr 21 | M | 6,077 | $64.25 | $390,447 | 268,769 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Apr 17 | Apr 21 | M | 12,590 | $71.93 | $905,599 | 281,359 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Apr 17 | Apr 21 | S | 18,667 | $96.50 | Sale −$1,801,366 | 262,692 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Apr 17 | Apr 21 | M · derivative | 6,077 | $64.25 | $390,447 | 26,833 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Apr 17 | Apr 21 | M · derivative | 12,590 | $71.93 | $905,599 | 27,699 | Yes | Form 4 |
| Cagnoni Pablo JPresident, Global Head of R&D | Apr 15 | Apr 17 | A | 27,892 | $0.00 | $0 | 262,692 | No | Form 4 |
| Meury WilliamChief Executive Officer | Apr 15 | Apr 17 | M | 125,000 | $0.00 | $0 | 161,101 | No | Form 4 |
| Stein Steven HCMO & Head of Late-Stage Dev. | Apr 15 | Apr 17 | A | 39,049 | $0.00 | $0 | 73,252 | No | Form 4 |
| Harrigan Edmund | Mar 31 | Apr 2 | A | 269 | $94.12 | $25,318 | 21,122 | No | Form 4 |
| 667, L.P. | Mar 31 | Apr 2 | A | 421 | $0.00 | $0 | 2,818,039 | No | Form 4 |
| 667, L.P. | Mar 31 | Apr 2 | A | 421 | $0.00 | $0 | 28,188,718 | No | Form 4 |
| Clancy Paul J | Mar 31 | Apr 2 | A | 265 | $94.12 | $24,942 | 23,741 | No | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Mar 25 | Mar 26 | F | 537 | $92.23 | $49,528 | 14,882 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Mar 17 | Mar 19 | M | 7,166 | $61.18 | $438,416 | 241,966 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Mar 17 | Mar 19 | M | 11,501 | $64.25 | $738,939 | 253,467 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Mar 17 | Mar 19 | S | 18,667 | $94.24 | Sale −$1,759,178 | 234,800 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Mar 17 | Mar 19 | M · derivative | 7,166 | $61.18 | $438,416 | 9,102 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Mar 17 | Mar 19 | M · derivative | 11,501 | $64.25 | $738,939 | 32,910 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Feb 19 | Feb 23 | M | 13,093 | $61.76 | $808,624 | 247,893 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Feb 19 | Feb 23 | M | 5,575 | $61.18 | $341,079 | 253,468 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Feb 19 | Feb 23 | S | 18,668 | $100.91 | Sale −$1,883,788 | 234,800 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Feb 19 | Feb 23 | M · derivative | 13,093 | $61.76 | $808,624 | 7,182 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Feb 19 | Feb 23 | M · derivative | 5,575 | $61.18 | $341,079 | 16,268 | Yes | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Feb 2 | Feb 4 | F | 185 | $102.67 | $18,994 | 34,065 | No | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Feb 2 | Feb 4 | F | 111 | $102.67 | $11,396 | 38,041 | No | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Jan 20 | Jan 21 | F | 429 | $102.62 | $44,024 | 34,250 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jan 16 | Jan 21 | A · derivative | 28,475 | $106.21 | $3,024,330 | 28,475 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jan 16 | Jan 21 | A · derivative | 19,932 | $106.21 | $2,116,978 | 19,932 | No | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Jan 16 | Jan 21 | A | 7,426 | $0.00 | $0 | 34,679 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jan 16 | Jan 21 | A · derivative | 2,425 | $106.21 | $257,559 | 2,425 | No | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Jan 16 | Jan 21 | A · derivative | 8,542 | $106.21 | $907,246 | 8,542 | No | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Jan 16 | Jan 21 | A | 8,911 | $0.00 | $0 | 38,152 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of US Oncology | Jan 16 | Jan 21 | A · derivative | 14,237 | $106.21 | $1,512,112 | 14,237 | No | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Jan 16 | Jan 21 | A · derivative | 4,218 | $106.21 | $447,994 | 4,218 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of US Oncology | Jan 7 | Jan 8 | S | 10,856 | $109.07 | Sale −$1,184,064 | 66,132 | Yes | Form 4 |
| Issa Mohamed KhairieEVP, Head of US Oncology | Jan 6 | Jan 8 | F | 8,264 | $106.66 | $881,438 | 76,988 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jan 5 | Jan 7 | S | 15,634 | $101.70 | Sale −$1,589,978 | 34,203 | Yes | Form 4 |
| Harrigan Edmund | Dec 31, 2025 | Jan 5 | A | 245 | $98.77 | $24,199 | 20,853 | No | Form 4 |
| Baker Felix | Dec 31, 2025 | Jan 5 | A | 328 | $0.00 | $0 | 2,817,618 | No | Form 4 |
| Baker Felix | Dec 31, 2025 | Jan 5 | A | 328 | $0.00 | $0 | 28,188,297 | No | Form 4 |
| Clancy Paul J | Dec 31, 2025 | Jan 5 | A | 241 | $98.77 | $23,804 | 23,476 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Dec 31, 2025 | Jan 5 | F | 13,292 | $98.77 | $1,312,851 | 49,837 | No | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Dec 31, 2025 | Jan 5 | F | 254 | $98.77 | $25,088 | 27,253 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Dec 19, 2025 | Dec 22, 2025 | M | 1,044 | $95.76 | $99,973 | 24,017 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Dec 19, 2025 | Dec 22, 2025 | M | 1,730 | $95.76 | $165,665 | 25,747 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Dec 19, 2025 | Dec 22, 2025 | S | 2,774 | $100.00 | Sale −$277,400 | 22,973 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Dec 19, 2025 | Dec 22, 2025 | M · derivative | 1,044 | $95.76 | $99,973 | not reported | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Dec 19, 2025 | Dec 22, 2025 | M · derivative | 1,730 | $95.76 | $165,665 | not reported | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Dec 18, 2025 | Dec 22, 2025 | S | 600 | $98.25 | Sale −$58,950 | 22,973 | Yes | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Dec 17, 2025 | Dec 18, 2025 | S | 4,323 | $97.26 | Sale −$420,455 | 27,507 | Yes | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Dec 16, 2025 | Dec 18, 2025 | S | 833 | $97.42 | Sale −$81,151 | 85,005 | Yes | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Dec 16, 2025 | Dec 18, 2025 | S | 53,175 | $97.29 | Sale −$5,173,396 | 31,830 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Dec 11, 2025 | Dec 12, 2025 | S | 255 | $94.94 | Sale −$24,210 | 60,011 | Yes | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Dec 10, 2025 | Dec 12, 2025 | S | 5,553 | $95.58 | Sale −$530,756 | 60,266 | Yes | Form 4 |
| Hoppenot Herve | Dec 8, 2025 | Dec 10, 2025 | F | 2,843 | $96.70 | $274,918 | 326,803 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Dec 2, 2025 | Dec 3, 2025 | S | 20,105 | $102.51 | Sale −$2,060,964 | 63,129 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Dec 1, 2025 | Dec 3, 2025 | S | 2,559 | $102.96 | Sale −$263,475 | 100,327 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Dec 1, 2025 | Dec 3, 2025 | F | 17,093 | $102.04 | $1,744,170 | 83,234 | Yes | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Dec 1, 2025 | Dec 3, 2025 | F | 326 | $102.04 | $33,265 | 85,838 | No | Form 4 |
| Hoffman Richard A.EVP & General Counsel | Dec 1, 2025 | Dec 3, 2025 | A | 9,466 | $0.00 | $0 | 9,466 | No | Form 4 |
| Hoffman Richard A.EVP & General Counsel | Dec 1, 2025 | Dec 3, 2025 | A · derivative | 43,301 | $102.04 | $4,418,434 | 43,301 | No | Form 4 |
| Hoffman Richard A.EVP & General Counsel | Dec 1, 2025 | Dec 3, 2025 | A · derivative | 23,665 | $0.00 | $0 | 23,665 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Nov 24, 2025 | Nov 25, 2025 | S | 600 | $103.00 | Sale −$61,800 | 23,573 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Nov 21, 2025 | Nov 25, 2025 | S | 169 | $102.00 | Sale −$17,238 | 24,173 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Nov 17, 2025 | Nov 19, 2025 | M | 278 | $64.25 | $17,862 | 26,847 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Nov 17, 2025 | Nov 19, 2025 | S | 278 | $104.36 | Sale −$29,012 | 26,569 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Nov 17, 2025 | Nov 19, 2025 | M · derivative | 278 | $64.25 | $17,862 | 8,883 | Yes | Form 4 |
| Hoppenot Herve | Nov 10, 2025 | Nov 12, 2025 | S | 187,500 | $105.46 | Sale −$19,773,750 | 329,646 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Nov 5, 2025 | Nov 7, 2025 | M | 1,194 | $83.83 | $100,093 | 104,080 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Nov 5, 2025 | Nov 7, 2025 | M | 2,995 | $95.76 | $286,801 | 107,075 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Nov 5, 2025 | Nov 7, 2025 | M | 1,044 | $95.76 | $99,973 | 108,119 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Nov 5, 2025 | Nov 7, 2025 | S | 5,233 | $102.20 | Sale −$534,813 | 102,886 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Nov 5, 2025 | Nov 7, 2025 | M · derivative | 1,194 | $83.83 | $100,093 | not reported | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Nov 5, 2025 | Nov 7, 2025 | M · derivative | 2,995 | $95.76 | $286,801 | not reported | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Nov 5, 2025 | Nov 7, 2025 | M · derivative | 1,044 | $95.76 | $99,973 | not reported | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Nov 4, 2025 | Nov 6, 2025 | M | 598 | $58.06 | $34,720 | 27,167 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Nov 4, 2025 | Nov 6, 2025 | S | 598 | $101.36 | Sale −$60,613 | 26,569 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Nov 4, 2025 | Nov 6, 2025 | M · derivative | 598 | $58.06 | $34,720 | 13,765 | Yes | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Nov 3, 2025 | Nov 5, 2025 | S | 3,074 | $94.02 | Sale −$289,017 | 29,241 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 15, 2025 | Oct 17, 2025 | M | 277 | $64.25 | $17,797 | 26,846 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 15, 2025 | Oct 17, 2025 | S | 277 | $85.13 | Sale −$23,581 | 26,569 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 15, 2025 | Oct 17, 2025 | M · derivative | 277 | $64.25 | $17,797 | 9,161 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 3, 2025 | Oct 6, 2025 | S | 3,501 | $85.54 | Sale −$299,476 | 26,569 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 2, 2025 | Oct 6, 2025 | M | 599 | $58.06 | $34,778 | 33,799 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 2, 2025 | Oct 6, 2025 | S | 599 | $87.65 | Sale −$52,502 | 33,200 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 2, 2025 | Oct 6, 2025 | F | 3,130 | $86.28 | $270,056 | 30,070 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 2, 2025 | Oct 6, 2025 | M · derivative | 599 | $58.06 | $34,778 | 14,363 | Yes | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Oct 1, 2025 | Oct 3, 2025 | F | 463 | $86.70 | $40,142 | 32,315 | No | Form 4 |
| Mayes Patrick AEVP & Chief Scientific Officer | Oct 1, 2025 | Oct 3, 2025 | F | 1,569 | $86.70 | $136,032 | 65,819 | No | Form 4 |
| Harrigan Edmund | Sep 30, 2025 | Oct 2, 2025 | A | 289 | $84.81 | $24,510 | 20,608 | No | Form 4 |
| Baker Felix | Sep 30, 2025 | Oct 2, 2025 | A | 388 | $0.00 | $0 | 2,817,290 | No | Form 4 |
| Baker Felix | Sep 30, 2025 | Oct 2, 2025 | A | 388 | $0.00 | $0 | 28,187,969 | No | Form 4 |
| Clancy Paul J | Sep 30, 2025 | Oct 2, 2025 | A | 285 | $84.81 | $24,171 | 23,235 | No | Form 4 |
| Gardner David HEVP, Chief Strategy Officer | Sep 22, 2025 | Sep 24, 2025 | A | 9,429 | $0.00 | $0 | 9,429 | No | Form 4 |
| Gardner David HEVP, Chief Strategy Officer | Sep 22, 2025 | Sep 24, 2025 | A · derivative | 23,573 | $0.00 | $0 | 23,573 | No | Form 4 |
| Gardner David HEVP, Chief Strategy Officer | Sep 22, 2025 | Sep 24, 2025 | A · derivative | 42,899 | $84.73 | $3,634,832 | 42,899 | No | Form 4 |
| Denton Sheila A.EVP & General Counsel | Sep 16, 2025 | Sep 18, 2025 | M | 278 | $64.25 | $17,862 | 33,478 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Sep 16, 2025 | Sep 18, 2025 | S | 278 | $83.15 | Sale −$23,116 | 33,200 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Sep 16, 2025 | Sep 18, 2025 | M · derivative | 278 | $64.25 | $17,862 | 9,438 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Sep 2, 2025 | Sep 4, 2025 | M | 598 | $58.06 | $34,720 | 33,798 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Sep 2, 2025 | Sep 4, 2025 | S | 598 | $84.97 | Sale −$50,812 | 33,200 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Sep 2, 2025 | Sep 4, 2025 | M · derivative | 598 | $58.06 | $34,720 | 14,962 | Yes | Form 4 |
| Basi Ramitpal KEVP, Human Resources | Aug 25, 2025 | Aug 27, 2025 | A | 6,506 | $0.00 | $0 | 6,506 | No | Form 4 |
| Basi Ramitpal KEVP, Human Resources | Aug 25, 2025 | Aug 27, 2025 | A · derivative | 16,265 | $0.00 | $0 | 16,265 | No | Form 4 |
| Basi Ramitpal KEVP, Human Resources | Aug 25, 2025 | Aug 27, 2025 | A · derivative | 29,230 | $84.76 | $2,477,535 | 29,230 | No | Form 4 |
| Denton Sheila A.EVP & General Counsel | Aug 15, 2025 | Aug 19, 2025 | M | 277 | $64.25 | $17,797 | 33,477 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Aug 15, 2025 | Aug 19, 2025 | S | 277 | $86.81 | Sale −$24,046 | 33,200 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Aug 15, 2025 | Aug 19, 2025 | M · derivative | 277 | $64.25 | $17,797 | 9,716 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Aug 4, 2025 | Aug 6, 2025 | M | 598 | $58.06 | $34,720 | 33,798 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Aug 4, 2025 | Aug 6, 2025 | S | 598 | $75.77 | Sale −$45,310 | 33,200 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Aug 4, 2025 | Aug 6, 2025 | M · derivative | 598 | $58.06 | $34,720 | 15,560 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 21, 2025 | Jul 23, 2025 | S | 3,706 | $67.94 | Sale −$251,786 | 102,886 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 16, 2025 | Jul 17, 2025 | S | 785 | $68.36 | Sale −$53,663 | 33,200 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 16, 2025 | Jul 17, 2025 | S | 983 | $68.36 | Sale −$67,198 | 40,540 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 16, 2025 | Jul 17, 2025 | S | 1,340 | $68.36 | Sale −$91,602 | 35,149 | Yes | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Jul 15, 2025 | Jul 17, 2025 | A · derivative | 10,961 | $0.00 | $0 | 10,961 | No | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Jul 15, 2025 | Jul 17, 2025 | A · derivative | 6,577 | $0.00 | $0 | 6,577 | No | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Jul 15, 2025 | Jul 17, 2025 | F | 182 | $68.25 | $12,422 | 9,755 | No | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Jul 15, 2025 | Jul 17, 2025 | A | 5,261 | $0.00 | $0 | 15,016 | No | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Jul 15, 2025 | Jul 17, 2025 | A · derivative | 13,154 | $0.00 | $0 | 13,154 | No | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Jul 15, 2025 | Jul 17, 2025 | A · derivative | 11,841 | $68.25 | $808,148 | 11,841 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of US Oncology | Jul 15, 2025 | Jul 17, 2025 | A | 8,769 | $0.00 | $0 | 85,252 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of US Oncology | Jul 15, 2025 | Jul 17, 2025 | A · derivative | 21,923 | $0.00 | $0 | 21,923 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of US Oncology | Jul 15, 2025 | Jul 17, 2025 | A · derivative | 19,735 | $68.25 | $1,346,914 | 19,735 | No | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2025 | Jul 17, 2025 | M | 3,330 | $64.25 | $213,953 | 29,834 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2025 | Jul 17, 2025 | S | 3,330 | $69.86 | Sale −$232,634 | 26,504 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2025 | Jul 17, 2025 | F | 703 | $68.25 | $47,980 | 25,801 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2025 | Jul 17, 2025 | A | 8,184 | $0.00 | $0 | 33,985 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2025 | Jul 17, 2025 | M · derivative | 3,330 | $64.25 | $213,953 | 9,993 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2025 | Jul 17, 2025 | A · derivative | 20,461 | $0.00 | $0 | 20,461 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2025 | Jul 17, 2025 | A · derivative | 18,419 | $68.25 | $1,257,097 | 18,419 | Yes | Form 4 |
| Hoppenot HerveSpecial Advisor to the CEO | Jul 15, 2025 | Jul 16, 2025 | F | 4,713 | $68.25 | $321,662 | 517,146 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 15, 2025 | Jul 16, 2025 | S | 1,192 | $69.86 | Sale −$83,273 | 37,630 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 15, 2025 | Jul 16, 2025 | F | 1,141 | $68.25 | $77,873 | 36,489 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 15, 2025 | Jul 16, 2025 | S | 1,177 | $69.86 | Sale −$82,225 | 35,929 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 15, 2025 | Jul 16, 2025 | F | 836 | $68.25 | $57,057 | 35,093 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 15, 2025 | Jul 16, 2025 | A | 6,430 | $0.00 | $0 | 41,523 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 16,077 | $0.00 | $0 | 16,077 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 14,472 | $68.25 | $987,714 | 14,472 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 15, 2025 | Jul 16, 2025 | F | 583 | $68.25 | $39,790 | 19,831 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 15, 2025 | Jul 16, 2025 | A | 4,482 | $0.00 | $0 | 24,313 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 3,362 | $68.25 | $229,457 | 3,362 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 15, 2025 | Jul 16, 2025 | F | 1,445 | $68.25 | $98,621 | 114,652 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 15, 2025 | Jul 16, 2025 | A | 11,107 | $0.00 | $0 | 125,759 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 27,769 | $0.00 | $0 | 27,769 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 24,998 | $68.25 | $1,706,114 | 24,998 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 15, 2025 | Jul 16, 2025 | F | 563 | $68.25 | $38,425 | 100,052 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 15, 2025 | Jul 16, 2025 | A | 6,430 | $0.00 | $0 | 106,482 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 16,077 | $0.00 | $0 | 16,077 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 14,472 | $68.25 | $987,714 | 14,472 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 15, 2025 | Jul 16, 2025 | F | 1,596 | $68.25 | $108,927 | 94,315 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 15, 2025 | Jul 16, 2025 | A | 12,277 | $0.00 | $0 | 106,592 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 30,692 | $0.00 | $0 | 30,692 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 27,629 | $68.25 | $1,885,679 | 27,629 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jul 15, 2025 | Jul 16, 2025 | F | 2,628 | $68.25 | $179,361 | 217,262 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jul 15, 2025 | Jul 16, 2025 | A | 17,538 | $0.00 | $0 | 234,800 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 43,846 | $0.00 | $0 | 43,846 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jul 15, 2025 | Jul 16, 2025 | A · derivative | 39,471 | $68.25 | $2,693,896 | 39,471 | No | Form 4 |
| Hoppenot HerveSpecial Advisor to the CEO | Jul 14, 2025 | Jul 16, 2025 | F | 4,961 | $69.98 | $347,171 | 521,859 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 14, 2025 | Jul 16, 2025 | F | 922 | $69.98 | $64,522 | 38,822 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 14, 2025 | Jul 16, 2025 | F | 595 | $69.98 | $41,638 | 37,106 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 14, 2025 | Jul 16, 2025 | F | 692 | $69.98 | $48,426 | 20,414 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 14, 2025 | Jul 16, 2025 | F | 1,407 | $69.98 | $98,462 | 116,097 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 14, 2025 | Jul 16, 2025 | F | 444 | $69.98 | $31,071 | 100,615 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 14, 2025 | Jul 16, 2025 | S | 14,952 | $68.47 | Sale −$1,023,763 | 97,466 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 14, 2025 | Jul 16, 2025 | F | 1,555 | $69.98 | $108,819 | 95,911 | Yes | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jul 14, 2025 | Jul 16, 2025 | F | 1,280 | $69.98 | $89,574 | 219,890 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 3, 2025 | Jul 7, 2025 | S | 2,682 | $68.16 | Sale −$182,805 | 43,636 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 3, 2025 | Jul 7, 2025 | S | 5,935 | $68.15 | Sale −$404,470 | 37,701 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 3, 2025 | Jul 7, 2025 | S | 10,903 | $68.15 | Sale −$743,039 | 39,744 | Yes | Form 4 |
| Hoppenot HerveSpecial Advisor to the CEO | Jul 2, 2025 | Jul 7, 2025 | F | 42,769 | $68.17 | $2,915,563 | 526,820 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 2, 2025 | Jul 7, 2025 | F | 6,809 | $68.17 | $464,170 | 46,318 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 2, 2025 | Jul 7, 2025 | M | 599 | $58.06 | $34,778 | 27,103 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 2, 2025 | Jul 7, 2025 | S | 599 | $68.61 | Sale −$41,097 | 26,504 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 2, 2025 | Jul 7, 2025 | M · derivative | 599 | $58.06 | $34,778 | 16,158 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 2, 2025 | Jul 7, 2025 | F | 9,055 | $68.17 | $617,279 | 50,647 | Yes | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 2, 2025 | Jul 7, 2025 | F | 11,589 | $68.17 | $790,022 | 117,504 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 2, 2025 | Jul 7, 2025 | F | 12,714 | $68.17 | $866,713 | 112,418 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 2, 2025 | Jul 7, 2025 | F | 897 | $68.17 | $61,148 | 21,106 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 2, 2025 | Jul 7, 2025 | F | 6,285 | $68.17 | $428,448 | 101,059 | No | Form 4 |
| Meury WilliamChief Executive Officer | Jul 2, 2025 | Jul 2, 2025 | A | 36,101 | $0.00 | $0 | 36,101 | No | Form 4 |
| Meury WilliamChief Executive Officer | Jul 2, 2025 | Jul 2, 2025 | A · derivative | 108,303 | $0.00 | $0 | 108,303 | No | Form 4 |
| Meury WilliamChief Executive Officer | Jul 2, 2025 | Jul 2, 2025 | A · derivative | 125,000 | $0.00 | $0 | 125,000 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of US Oncology | Jun 30, 2025 | Jul 2, 2025 | A | 27,812 | $0.00 | $0 | 76,483 | No | Form 4 |
| Harrigan Edmund | Jun 30, 2025 | Jul 2, 2025 | A | 367 | $68.10 | $24,993 | 20,319 | No | Form 4 |
| Clancy Paul J | Jun 30, 2025 | Jul 2, 2025 | A | 361 | $68.10 | $24,584 | 22,950 | No | Form 4 |
| Baker Brothers Life Sciences LP | Jun 30, 2025 | Jul 2, 2025 | A | 492 | $0.00 | $0 | 2,816,902 | No | Form 4 |
| Baker Brothers Life Sciences LP | Jun 30, 2025 | Jul 2, 2025 | A | 492 | $0.00 | $0 | 28,187,581 | No | Form 4 |
| Hoppenot HerveSpecial Advisor to the CEO | Jun 26, 2025 | Jun 30, 2025 | A | 6,016 | $0.00 | $0 | 569,589 | No | Form 4 |
| Hoppenot HerveSpecial Advisor to the CEO | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 18,438 | $70.81 | $1,305,595 | 18,438 | No | Form 4 |
| Hoppenot HerveSpecial Advisor to the CEO | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 18,050 | $0.00 | $0 | 18,050 | No | Form 4 |
| Meury WilliamChief Executive Officer | Jun 26, 2025 | Jun 30, 2025 | A · derivative | 110,630 | $70.81 | $7,833,710 | 110,630 | No | Form 4 |
| Baker Brothers Life Sciences LP | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 2,816,410 | No | Form 4 |
| Baker Brothers Life Sciences LP | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 28,187,089 | No | Form 4 |
| Baker Brothers Life Sciences LP | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| Baker Brothers Life Sciences LP | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| Harrigan Edmund | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 19,952 | No | Form 4 |
| Harrigan Edmund | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| Schaffert Susanne | Jun 10, 2025 | Jun 12, 2025 | F | 849 | $70.07 | $59,489 | 4,871 | No | Form 4 |
| Schaffert Susanne | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 7,389 | No | Form 4 |
| Schaffert Susanne | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| Clancy Paul J | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 22,589 | No | Form 4 |
| Clancy Paul J | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| High Katherine A | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 13,341 | No | Form 4 |
| High Katherine A | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| Bienaime Jean Jacques | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 20,841 | No | Form 4 |
| Bienaime Jean Jacques | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| Fouse Jacqualyn A | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 19,326 | No | Form 4 |
| Fouse Jacqualyn A | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| Brawley Otis W | Jun 10, 2025 | Jun 12, 2025 | A | 2,518 | $0.00 | $0 | 11,252 | No | Form 4 |
| Brawley Otis W | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 9,216 | $70.07 | $645,765 | 9,216 | No | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jun 3, 2025 | Jun 5, 2025 | M | 1,795 | $58.06 | $104,218 | 28,299 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jun 3, 2025 | Jun 5, 2025 | S | 1,795 | $68.00 | Sale −$122,060 | 26,504 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jun 3, 2025 | Jun 5, 2025 | M · derivative | 1,795 | $58.06 | $104,218 | 16,757 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jun 2, 2025 | Jun 3, 2025 | S | 651 | $64.88 | Sale −$42,237 | 22,003 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | May 30, 2025 | Jun 3, 2025 | S | 963 | $65.71 | Sale −$63,279 | 22,654 | Yes | Form 4 |
| Hoppenot HerveChairman / CEO | Apr 1, 2025 | Apr 3, 2025 | A | 66,899 | $0.00 | $0 | 563,573 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Apr 1, 2025 | Apr 3, 2025 | A | 11,159 | $0.00 | $0 | 96,362 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Apr 1, 2025 | Apr 3, 2025 | A | 10,982 | $0.00 | $0 | 107,344 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Apr 1, 2025 | Apr 3, 2025 | A | 37,198 | $0.00 | $0 | 104,165 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Apr 1, 2025 | Apr 3, 2025 | A | 20,967 | $0.00 | $0 | 125,132 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Apr 1, 2025 | Apr 3, 2025 | A | 18,598 | $0.00 | $0 | 110,123 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Apr 1, 2025 | Apr 3, 2025 | A | 18,970 | $0.00 | $0 | 129,093 | No | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Apr 1, 2025 | Apr 3, 2025 | A | 4,649 | $0.00 | $0 | 86,164 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Apr 1, 2025 | Apr 3, 2025 | A | 11,159 | $0.00 | $0 | 41,817 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Apr 1, 2025 | Apr 3, 2025 | A | 10,982 | $0.00 | $0 | 52,799 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Apr 1, 2025 | Apr 3, 2025 | A | 11,159 | $0.00 | $0 | 44,726 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Apr 1, 2025 | Apr 3, 2025 | A | 14,976 | $0.00 | $0 | 59,702 | No | Form 4 |
| 667, L.P. | Mar 31, 2025 | Apr 2, 2025 | A | 487 | $0.00 | $0 | 2,813,892 | No | Form 4 |
| 667, L.P. | Mar 31, 2025 | Apr 2, 2025 | A | 487 | $0.00 | $0 | 28,184,571 | No | Form 4 |
| Harrigan Edmund | Mar 31, 2025 | Apr 2, 2025 | A | 363 | $60.55 | $21,980 | 17,434 | Yes | Form 4 |
| Clancy Paul J | Mar 31, 2025 | Apr 2, 2025 | A | 358 | $60.55 | $21,677 | 20,071 | Yes | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Mar 25, 2025 | Mar 27, 2025 | F | 537 | $62.08 | $33,337 | 9,937 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Mar 14, 2025 | Mar 18, 2025 | S | 461 | $67.85 | Sale −$31,279 | 52,913 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Mar 14, 2025 | Mar 18, 2025 | S | 199 | $67.88 | Sale −$13,508 | 52,714 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Mar 14, 2025 | Mar 18, 2025 | S | 19,147 | $67.68 | Sale −$1,295,869 | 33,567 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Mar 4, 2025 | Mar 6, 2025 | M | 599 | $58.06 | $34,778 | 26,447 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Mar 4, 2025 | Mar 6, 2025 | S | 599 | $69.99 | Sale −$41,924 | 25,848 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Mar 4, 2025 | Mar 6, 2025 | M · derivative | 599 | $58.06 | $34,778 | 18,552 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Feb 26, 2025 | Feb 28, 2025 | M | 9,574 | $58.06 | $555,866 | 39,917 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Feb 26, 2025 | Feb 28, 2025 | S | 9,574 | $74.07 | Sale −$709,146 | 30,343 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Feb 26, 2025 | Feb 28, 2025 | S | 4,495 | $74.08 | Sale −$332,990 | 25,848 | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Feb 26, 2025 | Feb 28, 2025 | M · derivative | 9,574 | $58.06 | $555,866 | 19,151 | Yes | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Jan 31, 2025 | Feb 3, 2025 | A | 6,331 | $0.00 | $0 | 32,778 | No | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Jan 31, 2025 | Feb 3, 2025 | A | 10,552 | $0.00 | $0 | 81,515 | No | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Jan 21, 2025 | Jan 22, 2025 | F | 429 | $73.47 | $31,519 | 70,963 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jan 21, 2025 | Jan 22, 2025 | S | 12,352 | $72.69 | Sale −$897,867 | 66,967 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 28,202 | $71.93 | $2,028,570 | 28,202 | Yes | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 5,371 | $71.93 | $386,336 | 5,371 | No | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 12,086 | $71.93 | $869,346 | 12,086 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 40,289 | $71.93 | $2,897,988 | 40,289 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 3,432 | $71.93 | $246,864 | 3,432 | No | Form 4 |
| Hoppenot HerveChairman / CEO | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 55,510 | $71.93 | $3,992,834 | 55,510 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 20,144 | $71.93 | $1,448,958 | 20,144 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 25,516 | $71.93 | $1,835,366 | 25,516 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 14,772 | $71.93 | $1,062,550 | 14,772 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jan 17, 2025 | Jan 22, 2025 | A · derivative | 14,772 | $71.93 | $1,062,550 | 14,772 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jan 15, 2025 | Jan 17, 2025 | F | 10,692 | $72.46 | $774,742 | 79,319 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jan 15, 2025 | Jan 17, 2025 | F | 3,672 | $72.46 | $266,073 | 91,525 | No | Form 4 |
| Morrissey Michael JamesEVP, Head of Tech. Operations | Jan 15, 2025 | Jan 17, 2025 | F | 908 | $72.46 | $65,794 | 71,392 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jan 15, 2025 | Jan 17, 2025 | F | 3,158 | $72.46 | $228,829 | 53,374 | No | Form 4 |
| Issa Mohamed KhairieEVP, Head of US Oncology | Jan 6, 2025 | Jan 8, 2025 | A | 48,671 | $0.00 | $0 | 48,671 | No | Form 4 |
| Harrigan Edmund | Dec 31, 2024 | Jan 3, 2025 | A | 339 | $69.07 | $23,415 | 17,071 | Yes | Form 4 |
| Clancy Paul J | Dec 31, 2024 | Jan 3, 2025 | A | 331 | $69.07 | $22,862 | 19,713 | Yes | Form 4 |
| Baker Felix | Dec 31, 2024 | Jan 3, 2025 | A | 446 | $0.00 | $0 | 2,813,405 | No | Form 4 |
| Baker Felix | Dec 31, 2024 | Jan 3, 2025 | A | 446 | $0.00 | $0 | 28,184,084 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Dec 16, 2024 | Dec 17, 2024 | S | 650 | $69.31 | Sale −$45,052 | 23,312 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Dec 13, 2024 | Dec 17, 2024 | S | 650 | $70.64 | Sale −$45,916 | 23,962 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Dec 9, 2024 | Dec 11, 2024 | F | 1,510 | $72.11 | $108,886 | 56,532 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Dec 9, 2024 | Dec 11, 2024 | F | 873 | $72.11 | $62,952 | 85,203 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Nov 29, 2024 | Dec 3, 2024 | S | 360 | $75.60 | Sale −$27,216 | 36,341 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Nov 29, 2024 | Dec 3, 2024 | S | 5,683 | $75.37 | Sale −$428,328 | 30,658 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Nov 6, 2024 | Nov 8, 2024 | M | 1,424 | $72.27 | $102,912 | 59,466 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Nov 6, 2024 | Nov 8, 2024 | M | 2,256 | $68.62 | $154,807 | 61,722 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Nov 6, 2024 | Nov 8, 2024 | S | 1,424 | $82.00 | Sale −$116,768 | 60,298 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Nov 6, 2024 | Nov 8, 2024 | S | 2,256 | $78.21 | Sale −$176,442 | 58,042 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Nov 6, 2024 | Nov 8, 2024 | M · derivative | 1,424 | $72.27 | $102,912 | not reported | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Nov 6, 2024 | Nov 8, 2024 | M · derivative | 2,256 | $68.62 | $154,807 | not reported | Yes | Form 4 |
| Denton Sheila A.EVP & General Counsel | Oct 2, 2024 | Oct 4, 2024 | F | 2,136 | $67.63 | $144,458 | 30,343 | No | Form 4 |
| Heeson LeeEVP, Head of Incyte Intl | Oct 1, 2024 | Oct 3, 2024 | A | 26,447 | $0.00 | $0 | 26,447 | No | Form 4 |
| Harrigan Edmund | Sep 30, 2024 | Oct 2, 2024 | A | 378 | $66.10 | $24,986 | 16,732 | Yes | Form 4 |
| Clancy Paul J | Sep 30, 2024 | Oct 2, 2024 | A | 368 | $66.10 | $24,325 | 19,382 | Yes | Form 4 |
| Baker Bros. Advisors LP | Sep 30, 2024 | Oct 2, 2024 | A | 496 | $0.00 | $0 | 2,812,959 | No | Form 4 |
| Baker Bros. Advisors LP | Sep 30, 2024 | Oct 2, 2024 | A | 496 | $0.00 | $0 | 28,183,638 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Sep 13, 2024 | Sep 16, 2024 | S | 382 | $63.37 | Sale −$24,207 | 24,443 | Yes | Form 4 |
| Dickinson Jonathan ElliottEVP, General Manager, Europe | Sep 12, 2024 | Sep 16, 2024 | S | 1,117 | $62.30 | Sale −$69,589 | 43,723 | Yes | Form 4 |
| Dickinson Jonathan ElliottEVP, General Manager, Europe | Sep 12, 2024 | Sep 16, 2024 | S | 7,333 | $62.37 | Sale −$457,359 | 36,390 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Sep 12, 2024 | Sep 16, 2024 | S | 572 | $62.94 | Sale −$36,002 | 24,825 | Yes | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Aug 12, 2024 | Aug 14, 2024 | S | 11,608 | $60.63 | Sale −$703,793 | 90,011 | Yes | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 25, 2024 | Jul 29, 2024 | S | 15,571 | $70.00 | Sale −$1,089,970 | 36,701 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 16, 2024 | Jul 17, 2024 | S | 1,306 | $64.19 | Sale −$83,832 | 58,042 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 15, 2024 | Jul 17, 2024 | A | 9,925 | $0.00 | $0 | 60,459 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 15, 2024 | Jul 17, 2024 | F | 1,111 | $64.25 | $71,382 | 59,348 | Yes | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 22,205 | $64.25 | $1,426,671 | 22,205 | Yes | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 15, 2024 | Jul 17, 2024 | A | 12,572 | $0.00 | $0 | 96,145 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 15, 2024 | Jul 17, 2024 | F | 948 | $64.25 | $60,909 | 95,197 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 28,127 | $64.25 | $1,807,160 | 28,127 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 15, 2024 | Jul 17, 2024 | A | 7,278 | $0.00 | $0 | 52,821 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 15, 2024 | Jul 17, 2024 | F | 549 | $64.25 | $35,273 | 52,272 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 16,284 | $64.25 | $1,046,247 | 16,284 | No | Form 4 |
| Hoppenot HerveChairman / CEO | Jul 15, 2024 | Jul 17, 2024 | A | 41,025 | $0.00 | $0 | 501,635 | No | Form 4 |
| Hoppenot HerveChairman / CEO | Jul 15, 2024 | Jul 17, 2024 | F | 4,961 | $64.25 | $318,744 | 496,674 | No | Form 4 |
| Hoppenot HerveChairman / CEO | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 61,189 | $64.25 | $3,931,393 | 61,189 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jul 15, 2024 | Jul 17, 2024 | A | 19,851 | $0.00 | $0 | 221,919 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jul 15, 2024 | Jul 17, 2024 | F | 749 | $64.25 | $48,123 | 221,170 | No | Form 4 |
| Cagnoni Pablo JPresident, R&D | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 44,411 | $64.25 | $2,853,407 | 44,411 | No | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Jul 15, 2024 | Jul 17, 2024 | A | 2,646 | $0.00 | $0 | 10,474 | No | Form 4 |
| Trotta MatteoEVP, GM, Dermatology US | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 5,921 | $64.25 | $380,424 | 5,921 | No | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2024 | Jul 17, 2024 | A | 5,955 | $0.00 | $0 | 32,479 | No | Form 4 |
| Denton Sheila A.EVP & General Counsel | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 13,323 | $64.25 | $856,003 | 13,323 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 15, 2024 | Jul 17, 2024 | A | 7,278 | $0.00 | $0 | 86,625 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 15, 2024 | Jul 17, 2024 | F | 549 | $64.25 | $35,273 | 86,076 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 16,284 | $64.25 | $1,046,247 | 16,284 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 15, 2024 | Jul 17, 2024 | A | 5,073 | $0.00 | $0 | 25,863 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 15, 2024 | Jul 17, 2024 | F | 466 | $64.25 | $29,941 | 25,397 | No | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 3,783 | $64.25 | $243,058 | 3,783 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 15, 2024 | Jul 17, 2024 | A | 13,895 | $0.00 | $0 | 103,174 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 15, 2024 | Jul 17, 2024 | F | 1,555 | $64.25 | $99,909 | 101,619 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 15, 2024 | Jul 17, 2024 | A · derivative | 31,088 | $64.25 | $1,997,404 | 31,088 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 9, 2024 | Jul 11, 2024 | S | 8,148 | $60.00 | Sale −$488,880 | 50,534 | Yes | Form 4 |
| Tray ThomasPrincipal Accounting Officer | Jul 2, 2024 | Jul 3, 2024 | F | 844 | $59.02 | $49,813 | 20,790 | No | Form 4 |
| Swain Paula JEVP, Human Resources | Jul 2, 2024 | Jul 3, 2024 | F | 5,560 | $59.02 | $328,151 | 79,347 | No | Form 4 |
| Stein Steven HEVP & Chief Medical Officer | Jul 2, 2024 | Jul 3, 2024 | F | 8,316 | $59.02 | $490,810 | 89,279 | No | Form 4 |
| Stamoulis ChristianaEVP & Chief Financial Officer | Jul 2, 2024 | Jul 3, 2024 | F | 6,870 | $59.02 | $405,467 | 83,573 | No | Form 4 |
| Iyengar Vijay KEVP, GMAPPS | Jul 2, 2024 | Jul 3, 2024 | F | 5,706 | $59.02 | $336,768 | 45,543 | No | Form 4 |
| Flannelly Barry PEVP & General Manager US | Jul 2, 2024 | Jul 3, 2024 | F | 7,695 | $59.02 | $454,159 | 58,682 | No | Form 4 |
| Hoppenot HerveChairman / CEO | Jul 2, 2024 | Jul 3, 2024 | F | 41,723 | $59.02 | $2,462,491 | 460,610 | No | Form 4 |
| Harrigan Edmund | Jun 28, 2024 | Jul 2, 2024 | A | 409 | $60.62 | $24,794 | 16,354 | No | Form 4 |
| Clancy Paul J | Jun 28, 2024 | Jul 2, 2024 | A | 399 | $60.62 | $24,187 | 19,014 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Jun 28, 2024 | Jul 2, 2024 | A | 537 | $0.00 | $0 | 2,812,463 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Jun 28, 2024 | Jul 2, 2024 | A | 537 | $0.00 | $0 | 28,183,142 | No | Form 4 |
| Clancy Paul J | Jun 12, 2024 | Jun 14, 2024 | A | 2,830 | $0.00 | $0 | 18,615 | No | Form 4 |
| Clancy Paul J | Jun 12, 2024 | Jun 14, 2024 | A · derivative | 12,517 | $59.94 | $750,269 | 12,517 | No | Form 4 |
| Harrigan Edmund | Jun 12, 2024 | Jun 14, 2024 | A | 2,830 | $0.00 | $0 | 15,945 | No | Form 4 |
| Harrigan Edmund | Jun 12, 2024 | Jun 14, 2024 | A · derivative | 12,517 | $59.94 | $750,269 | 12,517 | No | Form 4 |
| Schaffert Susanne | Jun 12, 2024 | Jun 14, 2024 | F | 752 | $59.94 | $45,075 | 2,890 | No | Form 4 |
| Schaffert Susanne | Jun 12, 2024 | Jun 14, 2024 | A | 2,830 | $0.00 | $0 | 5,720 | No | Form 4 |